Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
DUSP3 | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 237.0 | Evidence | O | ||||
DUSP3 | BRAF | BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase | 37.90 | Evidence | |||||
DUSP3 | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 28.20 | Evidence | |||||
DUSP3 | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 24.90 | Evidence | |||||
DUSP3 | RPS6KA2 | RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 | 19.70 | Evidence | |||||
DUSP3 | MKNK1 | MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 | 19.70 | Evidence | |||||
DUSP3 | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 16.40 | Evidence | |||||
DUSP3 | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 16.40 | Evidence | |||||
DUSP3 | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 15.00 | Evidence | |||||
DUSP3 | RPS6KA4 | RPS6KA4, MSK2: Ribosomal protein S6 kinase alpha-4 | 15.00 | Evidence | |||||
DUSP3 | MAP2K1 | MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 | 13.80 | Evidence | |||||
DUSP3 | DAPK1 | DAPK1, DAPK: Death-associated protein kinase 1 | 11.40 | Evidence | |||||
DUSP3 | PRKCI | PRKCI, DXS1179E: Protein kinase C iota type | 11.20 | Evidence | |||||
DUSP3 | DUSP1 | DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 | 11.00 | Evidence | |||||
DUSP3 | STAT3 | 9.92 | Evidence | ||||||
DUSP3 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 8.96 | Evidence | |||||
DUSP3 | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 8.92 | Evidence | |||||
DUSP3 | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 8.79 | Evidence | |||||
DUSP3 | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 8.79 | Evidence | |||||
DUSP3 | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 7.97 | Evidence | |||||
DUSP3 | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 7.71 | Evidence | |||||
DUSP3 | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 7.71 | Evidence | |||||
DUSP3 | DUSP6 | DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 | 7.26 | Evidence | |||||
DUSP3 | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 7.26 | Evidence | |||||
DUSP3 | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 6.52 | Evidence | |||||
DUSP3 | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 6.52 | Evidence | |||||
DUSP3 | LYN | LYN: Tyrosine-protein kinase Lyn | 6.52 | Evidence | |||||
DUSP3 | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 6.52 | Evidence | |||||
DUSP3 | HLA-DMA | DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP | 6.27 | Evidence | |||||
DUSP3 | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 5.88 | Evidence | |||||
DUSP3 | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 5.88 | Evidence | |||||
DUSP3 | VAV1 | VAV1, VAV: Proto-oncogene vav | 5.88 | Evidence | |||||
DUSP3 | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 5.25 | Evidence | |||||
DUSP3 | RPS6KA3 | RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 | 4.87 | Evidence | |||||
DUSP3 | EPOR | EPOR: Erythropoietin receptor precursor | 4.18 | Evidence | |||||
DUSP3 | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 4.03 | Evidence | |||||
DUSP3 | NR4A2 | NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 | 3.07 | Evidence | |||||
DUSP3 | JUN | JUN: Transcription factor AP-1 | 3.07 | Evidence | |||||
DUSP3 | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 3.07 | Evidence | |||||
DUSP3 | PTPRR | PTPRR, ECPTP, PTPRQ: Receptor-type tyrosine-protein phosphatase R precursor | 3.07 | Evidence | |||||
DUSP3 | SORBS3 | SORBS3, SCAM1: Vinexin | 2.94 | Evidence | |||||
DUSP3 | TUBA1 | TUBA4A, TUBA1: Tubulin alpha-4A chain | 2.55 | Evidence | |||||
DUSP3 | HSF1 | HSF1, HSTF1: Heat shock factor protein 1 | 2.55 | Evidence | |||||
DUSP3 | TAL2 | TAL2: T-cell acute lymphocytic leukemia protein 2 | 2.54 | Evidence | |||||
DUSP3 | RAVER1 | RAVER1, KIAA1978: Ribonucleoprotein PTB-binding 1 | 2.54 | Evidence | |||||
DUSP3 | NFIA | NFIA, RP5-902P15.1-003, hCG_2032260: Nuclear factor I/A | 2.54 | Evidence | |||||
DUSP3 | SNCG | SNCG, BCSG1, PERSYN, PRSN: Gamma-synuclein | 2.42 | Evidence | |||||
DUSP3 | PEA15 | PEA15: Astrocytic phosphoprotein PEA-15 | 2.42 | Evidence | |||||
DUSP3 | ELK1 | ELK1: ETS domain-containing protein Elk-1 | 2.34 | Evidence | |||||
DUSP3 | HDAC4 | HDAC4, KIAA0288: Histone deacetylase 4 | 2.34 | Evidence | |||||
DUSP3 | CREBBP | CREBBP, CBP: CREB-binding protein | 2.19 | Evidence | |||||
DUSP3 | PTPRA | N/A | 1.99 | Evidence | |||||
DUSP3 | PLCB1 | PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- | 1.98 | Evidence | |||||
DUSP3 | SMAD2 | SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 | 1.98 | Evidence | |||||
DUSP3 | JUND | JUND: Transcription factor jun-D | 1.9 | Evidence | |||||
DUSP3 | ARAF | ARAF, ARAF1, PKS, PKS2: A-Raf proto-oncogene serine/threonine-protein kinase | 1.76 | Evidence | |||||
DUSP3 | TUBB | TUBB, TUBB5, OK/SW-cl.56: Tubulin beta chain | 1.7 | Evidence | |||||
DUSP3 | UBTF | UBTF, UBF, UBF1: Nucleolar transcription factor 1 | 1.7 | Evidence | |||||
DUSP3 | PPARA | PPARA, NR1C1, PPAR: Peroxisome proliferator-activated receptor alpha | 1.67 | Evidence | |||||
DUSP3 | ETS1 | ETS1, EWSR2: Protein C-ets-1 | 1.51 | Evidence | |||||
DUSP3 | STMN2 | STMN2, SCG10, SCGN10: Stathmin-2 | 1.50 | Evidence | |||||
DUSP3 | SH2D1A | SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A | 1.32 | Evidence | |||||
DUSP3 | PTPN7 | N/A | 1.30 | Evidence | |||||
DUSP3 | MAPK15 | N/A | 1.13 | Evidence | |||||
DUSP3 | MAPK9 | MAPK9, JNK2, PRKM9: Mitogen-activated protein kinase 9 | 1.13 | Evidence |